Thermo Fisher Scientific has introduced the new TaqPath Enteric Bacterial Select Panel for detecting the most common gastrointestinal (GI) bacteria.
The CE-IVD marked panel helps clinicians identify the root cause of an infection and swiftly provide the most suitable treatment for patients.
Validated and registered under the In Vitro Diagnostic Device Directive (IVDD) in May, the new panel uses polymerase chain reaction (PCR) technology to detect a range of common GI bacteria in stool samples.
